Under normal physiological conditions, MAP3K7 comes under the aegis of mitogen‐activated protein kinase (MAP3K) that undergoes quick response to TGF‐β.19 This protein is also found to regulate several pathways, such as JNK and NF‐κB pathway, that are commonly reported to participate in carcinogenesis.20 MAP3K7 inhibition is associated with the tumour survival rate. The gene discussed is NFKB1; the disease is neoplasm.